MACROGENICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.56 USD | +1.32% |
|
-5.52% | +51.35% |
| Apr. 26 | B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target | MT |
| Apr. 10 | North American Morning Briefing : Traders Await -2- | DJ |
Chart calendar MacroGenics, Inc.
b932558c71e1d577.j3CVqGAadSN7w7r4x9aXtJBCMFgzz_SM6BxwGhiZAEE.yzLGnAoqGmIDhIqCtr7m1aAhBAxUrMDngFAzYm7RMRvQFe3mAkgmSxaryQ~3a70b636b67760d20a63bf07d8ef405b
Upcoming events on MacroGenics, Inc.
Past events on MacroGenics, Inc.
| 2024-03-13 10:15 am | Barclays Global Healthcare Conference |
| 2024-03-12 09:20 am | Leerink Partners Global Biopharma Conference |
| 2024-03-07 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-07 04:01 pm | Q4 2023 Earnings Release |
| 2024-03-04 10:30 am | TD Cowen Health Care Conference |
| 2024-02-07 02:00 pm | Guggenheim Healthcare Talks Biotechnology Conference - Fireside Chat |
| 2024-01-11 10:30 am | JPMorgan Healthcare Conference |
| 2023-11-28 07:30 am | Evercore ISI HealthCONx Conference |
| 2023-11-14 03:00 pm | Stifel Healthcare Conference |
| 2023-11-08 10:30 am | BMO BioPharma Spotlight Series: Oncology |
| 2023-11-06 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-06 04:01 pm | Q3 2023 Earnings Release |
| 2023-09-11 02:30 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-06 10:30 am | Citi BioPharma Conference |
| 2023-08-09 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-09 04:01 pm | Q2 2023 Earnings Release |
| 2023-05-31 09:00 am | Annual General Meeting |
| 2023-05-15 09:30 am | JMP Securities Life Sciences Conference - Fireside Chat |
| 2023-05-09 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-09 04:01 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 64,2 50,2 27.91% | 105 76,7 36.8% | 77,4 83,9 -7.65% | 152 150 1.26% | 58,7 80,9 -27.36% | 70,4 |
|
EBITDA Million USD | Released Forecast Spread | -166 -201 17.39% | -119 -211 43.31% | -192 -189 -1.27% | -110 -51,0 -114.63% | -159 -127 -24.77% | -180 |
|
EBIT Million USD | Released Forecast Spread | -177 -192 7.62% | -131 -172 23.99% | -203 -196 -3.36% | -121 -128 5.19% | -168 -131 -28.08% | -167 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -152 -170 10.82% | -130 -165 21.46% | -202 -196 -3.2% | -120 -141 15.06% | -9,06 -3,44 -163.61% | -169 |
|
Net income Million USD | Released Forecast Spread | -152 -170 10.79% | -130 -166 21.88% | -202 -195 -3.67% | -120 -131 8.9% | -9,06 24,3 -137.24% | -169 |
|
EPS USD | Released Forecast Spread | -3,16 -3,56 11.14% | -2,47 -3,10 20.25% | -3,37 -3,26 -3.43% | -1,95 -1,88 -3.51% | -0,15 0,43 -135.11% | -2,60 |
| Announcement Date | 25/02/20 | 25/02/21 | 24/02/22 | 15/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14,1 22,8 -38.03% | 11,1 23,2 -52.11% | 26,0 14,1 84.46% | 41,7 29,3 42.54% | 73,1 67,1 8.95% | 24,5 96,2 -74.53% | 13,1 30,0 -56.15% | 10,4 52,1 -80.05% | 10,7 32,6 -67.15% | 15,2 | 17,1 | 13,5 | 20,3 | 12,5 |
|
EBITDA Million USD | Released Forecast Spread | -47,5 -16,0 -197.11% | -47,5 | -45,8 | -44,1 | -42,1 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -58,2 -50,2 -15.99% | -66,6 -45,4 -46.68% | -41,8 -56,6 26.18% | -25,0 -39,7 37.11% | 12,0 -2,90 512.58% | -38,4 32,6 -217.78% | -45,0 -28,2 -59.26% | -35,5 1,21 -3035.51% | -49,4 -18,2 -170.94% | -44,3 | -43,7 | -50,3 | -39,4 | -57,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -58,0 -50,3 -15.41% | -66,4 -47,7 -39.3% | -41,3 -56,2 26.54% | -24,8 -41,4 40.14% | 12,8 -9,10 240.67% | -38,0 25,7 -247.72% | 57,5 -28,4 302.64% | 17,6 1,19 1369.57% | -46,1 -10,3 -347.1% | -43,5 | -42,0 | -48,9 | -38,0 | -57,6 |
|
Net income Million USD | Released Forecast Spread | -58,0 -49,7 -16.68% | -66,4 -47,6 -39.58% | -41,3 -57,4 27.99% | -24,8 -36,9 32.79% | 12,8 0,65 1859.98% | -38,0 40,0 -194.92% | 57,5 -30,0 291.75% | 17,6 2,53 594.25% | -46,1 -12,7 -262.04% | -43,1 | -42,1 | -48,0 | -39,1 | -57,6 |
|
EPS USD | Released Forecast Spread | -0,95 -0,80 -18.74% | -1,08 -0,83 -30.68% | -0,67 -0,97 30.93% | -0,40 -0,44 8.9% | 0,21 0,25 -14.59% | -0,61 0,59 -202.76% | 0,92 -0,50 282.49% | 0,28 -0,01 2636.23% | -0,75 -0,15 -401% | -0,65 | -0,64 | -0,70 | -0,60 | -0,90 |
| Announcement Date | 24/02/22 | 03/05/22 | 08/08/22 | 03/11/22 | 15/03/23 | 09/05/23 | 09/08/23 | 06/11/23 | 07/03/24 | - | - | - | - | - |
More events
Past sector events for MacroGenics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MGNX Stock
- Calendar MacroGenics, Inc.
